{
  "nctId": "NCT02501538",
  "briefTitle": "Continuous Diffusion of Oxygen (CDO) Treatment for Healing of Diabetic Foot Ulcers",
  "officialTitle": "Continuous Diffusion of Oxygen (CDO) Treatment for Healing of Diabetic Foot Ulcers",
  "protocolDocument": {
    "nctId": "NCT02501538",
    "filename": "Prot_SAP_ICF_000.pdf",
    "label": "Study Protocol, Statistical Analysis Plan, and Informed Consent Form",
    "date": "2018-09-25",
    "uploadDate": "2020-05-27T12:16",
    "size": 366603,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT02501538/document/Prot_SAP_ICF_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": true
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "NA",
  "interventionModel": "SINGLE_GROUP",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 23,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2015-06",
    "completionDate": "2020-01-10",
    "primaryCompletionDate": "2019-01-10",
    "firstSubmitDate": "2015-06-01",
    "firstPostDate": "2015-07-17"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Male or female subjects of all races and ethnicities, age 18-89\n* Diagnosis of diabetes mellitus\n* Has a diabetic foot ulcer\n\nExclusion Criteria:\n\n* End-stage renal disease (ESRD)\n* Has untreated foot ulcer at time of study\n* HIV, hepatitis, autoimmune disease, Systemic lupus erythematous (SLE), Raynaud's disease\n* Ankle-Brachial Index (ABI) \\< 0.4\n* Unable or unwilling to provide informed consent",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "maximumAge": "89 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Tissue Oxygenation as Measured by Hyperspectral Imaging",
        "description": "Hyperspectral (HyperMed, Inc.) images were taken for evaluation of tissue oxygenation following debridement at Visit 1 (day 0), visit 2 (day 7), visit 3 (day 14), visit 4 (day 21). Two images were taken of the study foot - one of the plantar surface and one of the dorsal surface to evaluate the oxygenation of the entire foot. Measurements of oxygenated hemoglobin are generated by the camera for each image. Results are reported in aggregate as mean/standard error for all time points.",
        "timeFrame": "21 days"
      },
      {
        "measure": "Tissue Perfusion as Measured by TCPO2",
        "description": "Transcutaneous oxygen pressure (TCPO2) was measured at visit 1 (day 0), visit 2 (day 7), visit 3 (day 14), visit 4 (day 21) to assess perfusion of the tissue. This is measured at the medial and lateral foot to include both major blood vessels to the foot. Reported here as aggregate mean over all time points.",
        "timeFrame": "21 days"
      }
    ],
    "secondary": [
      {
        "measure": "Change in Levels of Growth Factors and Cytokines Involved in Wound Healing",
        "description": "Comparison of measurements inflammatory cytokines: Interleukin 6 (IL-6), Interleukin 8 (IL-8), tumor necrosis factor (TNF)-α and growth factors: vascular endothelial growth factor (VEGF), platelet derived growth factor (PDGF), insulin derived growth factor (IGF), transforming growth factor beta (TGF)-β. These are reported as log fold change by delta delta ct.\n\nEvaluated from tissue samples obtained at visit 1 (day 0), visit 2 (day 7), visit 3 (day 14), visit 4 (day 21).",
        "timeFrame": "21 days"
      },
      {
        "measure": "Evaluate Changes in Bacterial Infection",
        "description": "Tissue samples sent for 16s rRNA quantitative culture. Reported in aggregate for each visit that corresponds to Visit 1 (day 0), visit 2 (day 7), visit 3 (day 14), visit 4 (day 21).",
        "timeFrame": "21 days"
      },
      {
        "measure": "Percent Wound Area Reduction",
        "description": "Percent change of the wound area (measured in cm\\^2) of visit 2 (day 7), visit 3 (day 14), and visit 4 (day 21) compared to baseline.\n\nPercent area reduction = initial surface area (length in cm x width in cm) minus current surface area (length in cm x width in cm), divided by initial surface area. multiplied by 100 to get percentage.",
        "timeFrame": "21 days"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 2,
      "secondaryCount": 3,
      "otherCount": 0,
      "totalCount": 5
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": false,
      "isMasked": false,
      "interventionModel": "SINGLE_GROUP"
    },
    "overallComplexityScore": 39,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-22T02:29:09.422Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}